Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 7 (2010), Issue 10 (October)

1. Desquamative interstitial pneumonia.
   Histopathology. [Abstract] [Full-text]
2. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study.
   Br J Psychiatry, 197(4): 285-90. [Abstract] [Full-text]
3. Does cannabidiol protect against the negative effects of THC?
   Br J Psychiatry, 197(4): 259-60. [Abstract] [Full-text]
4. Nightlife young risk behaviours in Mediterranean versus other European cities: are stereotypes true?
   Eur J Public Health. [Abstract] [Full-text]
5. Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.
   Neurotox Res, 18(3): 211-28. [Abstract] [Full-text]
6. High frequency plant regeneration from leaf derived callus of high Δ9-tetrahydrocannabinol yielding Cannabis sativa L.
   Planta Med, 76(14): 1629-33. [Abstract] [Full-text]
7. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
   Psychiatry Res, 179(3): 291-6. [Abstract] [Full-text]
8. Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits.
   Biol Psychiatry, 68(8): 762-9. [Abstract] [Full-text]
9. Smoking behavior among low-income black adults: patterns and correlates of smoking trajectories.
   Nicotine Tob Res, 12(10): 1019-28. [Abstract] [Full-text]
10. Exposure to a high-fat diet decreases sensitivity to Δ(9)-tetrahydrocannabinol-induced motor effects in female rats.
    Neuropharmacology. [Abstract] [Full-text]
11. Δ(9)-tetrahydrocannabinol and its major metabolite Δ(9)-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    J Pharm Sci. [Abstract] [Full-text]
12. Enhancing clinical research with alcohol, tobacco and cannabis problems and dependence.
    Drug Alcohol Rev, 29(5): 483-90. [Abstract] [Full-text]
13. Testing a developmental cascade model of adolescent substance use trajectories and young adult adjustment.
    Dev Psychopathol, 22(4): 933-48. [Abstract] [Full-text]
14. From child maltreatment to adolescent cannabis abuse and dependence: a developmental cascade model.
    Dev Psychopathol, 22(4): 883-97. [Abstract] [Full-text]
15. Testing a developmental cascade model of adolescent substance use trajectories and young adult adjustment.
    Dev Psychopathol, 22(4): 933-48. [Abstract] [Full-text]
16. From child maltreatment to adolescent cannabis abuse and dependence: a developmental cascade model.
    Dev Psychopathol, 22(4): 883-97. [Abstract] [Full-text]
17. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Psychiatry Res, 179(3): 291-6. [Abstract] [Full-text]
18. Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.
    Neurotox Res, 18(3): 211-28. [Abstract] [Full-text]
19. A parallel process growth mixture model of conduct problems and substance use with risky sexual behavior.
    Drug Alcohol Depend, 111(3): 207-14. [Abstract] [Full-text]
20. Assessment of addiction severity among ritual users of ayahuasca.
    Drug Alcohol Depend, 111(3): 257-61. [Abstract] [Full-text]
21. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.
    CMAJ, 182(14): E694-701. [Abstract] [Full-text]
22. Evidence That Familial Liability for Psychosis Is Expressed as Differential Sensitivity to Cannabis: An Analysis of Patient-Sibling and Sibling-Control Pairs.
    Arch Gen Psychiatry. [Abstract] [Full-text]
23. Cannabis use in palliative care - an examination of the evidence and the implications for nurses.
    J Clin Nurs, 19(17): 2454-62. [Abstract] [Full-text]
24. The impact of maternal age on the effects of prenatal alcohol exposure on attention.
    Alcohol Clin Exp Res, 34(10): 1813-21. [Abstract] [Full-text]
25. Marijuana use and testicular germ cell tumors.
    Cancer. [Abstract] [Full-text]
26. Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol).
    Psychopharmacology (Berl). [Abstract] [Full-text]
27. Legionnaires disease in cannabis smokers.
    Chest, 138(4): 989-91. [Abstract] [Full-text]
28. Cannabis use at a young age is associated with psychotic experiences.
    Psychol Med. [Abstract] [Full-text]
29. A meta-analytic review of school-based prevention for cannabis use.
    Health Educ Behav, 37(5): 709-23. [Abstract] [Full-text]
30. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia.
    Mov Disord, 25(13): 2188-94. [Abstract] [Full-text]
31. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
    J Psychiatr Res, 44(14): 944-55. [Abstract] [Full-text]
32. Variations in health and health behaviors by nativity among pregnant Black women in Philadelphia.
    Am J Public Health, 100(11): 2185-92. [Abstract] [Full-text]
33. Patterns of polydrug use in Great Britain: Findings from a national household population survey.
    Drug Alcohol Depend. [Abstract] [Full-text]
34. Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.
    Harm Reduct J, 7: 22. [Abstract] [Full-text]
35. Variations in health and health behaviors by nativity among pregnant Black women in Philadelphia.
    Am J Public Health, 100(11): 2185-92. [Abstract] [Full-text]
36. Marijuana use and high school dropout: the influence of unobservables.
    Health Econ, 19(11): 1281-99. [Abstract] [Full-text]
37. Marijuana use and high school dropout: the influence of unobservables.
    Health Econ, 19(11): 1281-99. [Abstract] [Full-text]
38. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    J Mass Spectrom, 45(10): 1186-94. [Abstract] [Full-text]
39. The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors.
    Psychopharmacology (Berl). [Abstract] [Full-text]
40. The Potential for Clinical Use of Cannabinoids in Treatment of Cardiovascular Diseases.
    Cardiovasc Ther. [Abstract] [Full-text]
41. Effect of Substance Abuse on Defibrillation Threshold in Patients with Implantable Cardioverter-Defibrillator.
    Pacing Clin Electrophysiol. [Abstract] [Full-text]
42. The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density.
    Neuroscience, 171(1): 40-9. [Abstract] [Full-text]
43. Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit.
    Women Birth. [Abstract] [Full-text]
44. Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety.
    Life Sci, 87(17): 572-8. [Abstract] [Full-text]
45. Associations among sleep problems, learning difficulties and substance use in adolescence.
    J Adolesc. [Abstract] [Full-text]
46. Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia.
    Biol Psychiatry. [Abstract] [Full-text]
47. The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density.
    Neuroscience, 171(1): 40-9. [Abstract] [Full-text]
48. The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density.
    Neuroscience, 171(1): 40-9. [Abstract] [Full-text]
49. Common and drug-specific genetic influences on subjective effects to alcohol, tobacco and marijuana use.
    Addiction. [Abstract] [Full-text]
50. Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats.
    J Pharmacol Exp Ther, 335(2): 294-301. [Abstract] [Full-text]
51. Direct detection of Δ9-tetrahydrocannabinol in aqueous samples using a homogeneous increasing fluorescence immunoassay (HiFi).
    Anal Bioanal Chem, 398(5): 2133-40. [Abstract] [Full-text]
52. Substance use in patients with sexually transmitted infections: results from a national U.S. survey.
    Am J Addict, 19(6): 504-9. [Abstract] [Full-text]
53. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder.
    Am J Addict, 19(6): 481-9. [Abstract] [Full-text]
54. Adolescent Substance Abuse: The Effects of Alcohol and Marijuana on Neuropsychological Performance.
    Alcohol Clin Exp Res. [Abstract] [Full-text]
55. Substance use in patients with sexually transmitted infections: results from a national U.S. survey.
    Am J Addict, 19(6): 504-9. [Abstract] [Full-text]
56. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder.
    Am J Addict, 19(6): 481-9. [Abstract] [Full-text]
57. Direct detection of Δ9-tetrahydrocannabinol in aqueous samples using a homogeneous increasing fluorescence immunoassay (HiFi).
    Anal Bioanal Chem, 398(5): 2133-40. [Abstract] [Full-text]
58. Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats.
    J Pharmacol Exp Ther, 335(2): 294-301. [Abstract] [Full-text]
59. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States.
    Dig Dis Sci, 55(11): 3113-9. [Abstract] [Full-text]
60. Potential exposure to anti-drug advertising and drug-related attitudes, beliefs, and behaviors among United States youth, 1995-2006.
    Addict Behav. [Abstract] [Full-text]
61. The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States.
    Dig Dis Sci, 55(11): 3113-9. [Abstract] [Full-text]
62. Measurement of multiple drugs in urine, water, and on surfaces using fluorescence covalent microbead immunosorbent assay.
    Toxicol Mech Methods, 20(9): 587-93. [Abstract] [Full-text]
63. Measurement of multiple drugs in urine, water, and on surfaces using fluorescence covalent microbead immunosorbent assay.
    Toxicol Mech Methods, 20(9): 587-93. [Abstract] [Full-text]
64. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.
    Schizophr Bull, 36(6): 1115-30. [Abstract] [Full-text]
65. Ethnic identity and the risk of schizophrenia in ethnic minorities: a case-control study.
    Schizophr Bull, 36(6): 1149-56. [Abstract] [Full-text]
66. Persecutory ideation and insomnia: findings from the second British National Survey of Psychiatric Morbidity.
    J Psychiatr Res, 44(15): 1021-6. [Abstract] [Full-text]
67. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned?
    J Psychiatr Res, 44(15): 993-1004. [Abstract] [Full-text]
68. White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study.
    J Psychiatry Neurosci, 35(6): 409-12. [Abstract] [Full-text]
69. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.
    Eur Neuropsychopharmacol, 20(12): 855-65. [Abstract] [Full-text]
70. Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide follow-up study of Danish substance users in treatment.
    Drug Alcohol Depend. [Abstract] [Full-text]
71. POMD11 Cannabinoids are neuroprotective in a human cell culture model of Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 81(11): e60. [Abstract] [Full-text]
72. Preventing substance use among early Asian-American adolescent girls: initial evaluation of a web-based, mother-daughter program.
    J Adolesc Health, 47(5): 529-32. [Abstract] [Full-text]
73. Preventing substance use among early Asian-American adolescent girls: initial evaluation of a web-based, mother-daughter program.
    J Adolesc Health, 47(5): 529-32. [Abstract] [Full-text]
74. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.
    Eur Neuropsychopharmacol, 20(12): 855-65. [Abstract] [Full-text]
75. White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study.
    J Psychiatry Neurosci, 35(6): 409-12. [Abstract] [Full-text]
76. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned?
    J Psychiatr Res, 44(15): 993-1004. [Abstract] [Full-text]
77. Persecutory ideation and insomnia: findings from the second British National Survey of Psychiatric Morbidity.
    J Psychiatr Res, 44(15): 1021-6. [Abstract] [Full-text]
78. Ethnic identity and the risk of schizophrenia in ethnic minorities: a case-control study.
    Schizophr Bull, 36(6): 1149-56. [Abstract] [Full-text]
79. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.
    Schizophr Bull, 36(6): 1115-30. [Abstract] [Full-text]
80. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.
    Eur Neuropsychopharmacol, 20(12): 855-65. [Abstract] [Full-text]
81. Central nervous system effects of haloperidol on THC in healthy male volunteers.
    J Psychopharmacol, 24(11): 1697-708. [Abstract] [Full-text]
82. Bullying behaviour and substance abuse among underage psychiatric inpatient adolescents.
    Eur Psychiatry, 25(7): 382-9. [Abstract] [Full-text]
83. Disruptive symptoms in childhood and adolescence and early initiation of tobacco and cannabis use: the Gazel Youth study.
    Eur Psychiatry, 25(7): 402-8. [Abstract] [Full-text]
84. A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats.
    Behav Pharmacol. [Abstract] [Full-text]
85. Agreement between Maternal Cannabis Use during Pregnancy according to Self-Report and Urinalysis in a Population-Based Cohort: The Generation R Study.
    Eur Addict Res, 17(1): 37-43. [Abstract] [Full-text]
86. The environment and susceptibility to schizophrenia.
    Prog Neurobiol. [Abstract] [Full-text]
87. Factors affecting criminal recidivism among participants in the Magistrates Early Referral Into Treatment (MERIT) program in New South Wales, Australia.
    Drug Alcohol Rev, 29(6): 684-8. [Abstract] [Full-text]
88. Factors affecting criminal recidivism among participants in the Magistrates Early Referral Into Treatment (MERIT) program in New South Wales, Australia.
    Drug Alcohol Rev, 29(6): 684-8. [Abstract] [Full-text]
89. Disruptive symptoms in childhood and adolescence and early initiation of tobacco and cannabis use: the Gazel Youth study.
    Eur Psychiatry, 25(7): 402-8. [Abstract] [Full-text]
90. Bullying behaviour and substance abuse among underage psychiatric inpatient adolescents.
    Eur Psychiatry, 25(7): 382-9. [Abstract] [Full-text]
91. Central nervous system effects of haloperidol on THC in healthy male volunteers.
    J Psychopharmacol, 24(11): 1697-708. [Abstract] [Full-text]
92. Childhood attention deficit hyperactivity disorder, substance use, and adult functioning among incarcerated women.
    J Atten Disord, 14(3): 273-80. [Abstract] [Full-text]
93. An exploratory study of substance use and misuse among college students with and without ADHD and other disabilities.
    J Atten Disord, 14(3): 205-15. [Abstract] [Full-text]
94. Consumption of medicines, alcohol, tobacco and cannabis among university students: a 2-year follow-up.
    Int J Public Health. [Abstract] [Full-text]
95. Marijuana Use Among Latino Adolescents: Gender Differences in Protective Familial Factors.
    Subst Use Misuse. [Abstract] [Full-text]
96. An exploratory study of substance use and misuse among college students with and without ADHD and other disabilities.
    J Atten Disord, 14(3): 205-15. [Abstract] [Full-text]
97. Childhood attention deficit hyperactivity disorder, substance use, and adult functioning among incarcerated women.
    J Atten Disord, 14(3): 273-80. [Abstract] [Full-text]
98. Condom use during most recent vaginal intercourse event among a probability sample of adults in the United States.
    J Sex Med, 7: 362-73. [Abstract] [Full-text]
99. An event-level analysis of the sexual characteristics and composition among adults ages 18 to 59: results from a national probability sample in the United States.
    J Sex Med, 7: 346-61. [Abstract] [Full-text]
100. Sexual behaviors and condom use at last vaginal intercourse: a national sample of adolescents ages 14 to 17 years.
     J Sex Med, 7: 305-14. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.